"Few if any names in cancer research
are as widely known as Kanematsu Sugiura’s... Possibly the highest regard in which his
work is held is best characterized by a comment made by an investigator
in cancer research from Russia. He said, "When Dr Sugiura publishes, we know we don’t
have to repeat the study, for we would obtain the same results he has reported."" So
wrote Dr C Chester Stock, Dr Kanematsu Sugiura, arguably America’s leading cancer
biochemist of the ‘70s.
West Germany: Dr Hans Nieper: former
Director of the Department of Medicine
at Silbersee Hospital in Hanover in 1972,
Dr Nieper told reporters: "After more than twenty years of such specialised work,
I have found non-toxic nitrilosides that is, laetrile far superior to any other
known cancer treatment or preventative. In my opinion,
it is the only existing possibility
for the ultimate control of cancer."
Canada: Dr N R Bouziane
former Director of Research Laboratories at St Jeanne D’Arc Hospital in Montreal: his
repeated successes in treating cancers with laetrile were written up in the Cancer
News Journal, Jan/April 1971, p.20 under the article heading "The Laetrile Story".
Philippines: Dr Manuel Navarro, former Professor of Medicine
and Surgery at the University of Santo Tomas, Manila. Associate
Member of the National
Research Council of the Philippines "It is my carefully considered clinical judgement,
as a practising oncologist and researcher in this field, that I have obtained most
significant and encouraging results with the use of laetrile-amygdalin in the treatment
of terminal cancer patients... "
Mexico: Dr Ernesto Contreras,
one of Mexico’s leading medical specialists, has operated the Oasis Hospital in
Tijuana,
Mexico for over 30 years, treating cancer patients with laetrile
Italy: Professor Etore Guidetti of the University of Turin Medical School
addressed the Conference of the International Union Against Cancer held in
Brazil in 1954 and announced startling results with laetrile in successfully
combating many types of cancer,
including cervix, breast, uterus and rectum. After his speech, an American doctor
rose in
the audience, challenging the Italian professor that laetrile had been found to be
worthless in the United States. Dr Guidetti was abrupt and dismissive: "I care not
what was determined in the United States. I am merely reporting what I saw in my own
clinic ."
Belgium: Professor Joseph H Maisin, Sr from the
University of Louvain, Director of the Institute of Cancer. Professor Maisin was also
President Emeritus of the International League Against Cancer which holds the
International Cancer Congress every four years.
United States:
Among the many, Dr John A Richardson of Albany, New York, Dr Ernst T Krebs Jr, who developed laetrile. Dr Harold W Manner,
professor of biology, Loyola University, Chicago. Dr H Ray Evers, Dr Dan Dotson and
Dr John A Morrone of the Jersey City Medical
Center. 60-year cancer researcher Dr Kanematsu Sugiura of Memorial Sloan-Kettering,
and Dr Dean Burk, a founding member of the American National Cancer Institute and head
of its Cytochemistry Section.
